Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus
Citations Over TimeTop 1% of 2016 papers
Abstract
HIV-1-specific broadly neutralizing antibodies (bNAbs) can protect rhesus monkeys against simian-human immunodeficiency virus (SHIV) challenge. However, the site of antibody interception of virus and the mechanism of antibody-mediated protection remain unclear. We administered a fully protective dose of the bNAb PGT121 to rhesus monkeys and challenged them intravaginally with SHIV-SF162P3. In PGT121-treated animals, we detected low levels of viral RNA and viral DNA in distal tissues for seven days following challenge. Viral RNA-positive tissues showed transcriptomic changes indicative of innate immune activation, and cells from these tissues initiated infection after adoptive transfer into naïve hosts. These data demonstrate that bNAb-mediated protection against a mucosal virus challenge can involve clearance of infectious virus in distal tissues.
Related Papers
- → SIV Vpx Is Essential for Macrophage Infection but Not for Development of AIDS(2014)24 cited
- → Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques(1997)68 cited
- → Increased Stability and Limited Proliferation of CD4 + Central Memory T Cells Differentiate Nonprogressive Simian Immunodeficiency Virus (SIV) Infection of Sooty Mangabeys from Progressive SIV Infection of Rhesus Macaques(2014)20 cited
- → Multi-Low-Dose Mucosal Simian Immunodeficiency Virus SIVmac239 Challenge of Cynomolgus Macaques Immunized with “Hyperattenuated” SIV Constructs(2009)19 cited
- → Postexposure Immunotherapy of Simian Immunodeficiency Virus (SIV) Infected Rhesus With an SIV Immunogen(1989)14 cited